State of Wyoming Acquires 1,975 Shares of Astera Labs, Inc. $ALAB

State of Wyoming grew its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 239.1% during the first quarter, HoldingsChannel.com reports. The firm owned 2,801 shares of the company’s stock after buying an additional 1,975 shares during the period. State of Wyoming’s holdings in Astera Labs were worth $307,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also made changes to their positions in ALAB. Lido Advisors LLC grew its stake in shares of Astera Labs by 0.5% during the fourth quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after purchasing an additional 57 shares during the period. Perigon Wealth Management LLC lifted its stake in Astera Labs by 6.2% in the fourth quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock valued at $208,000 after buying an additional 73 shares during the period. Sound Income Strategies LLC boosted its holdings in Astera Labs by 9.2% during the fourth quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after buying an additional 76 shares during the last quarter. Venturi Wealth Management LLC boosted its holdings in Astera Labs by 2.6% during the fourth quarter. Venturi Wealth Management LLC now owns 3,284 shares of the company’s stock worth $546,000 after buying an additional 84 shares during the last quarter. Finally, Goldstein Advisors LLC boosted its holdings in Astera Labs by 5.8% during the fourth quarter. Goldstein Advisors LLC now owns 1,611 shares of the company’s stock worth $268,000 after buying an additional 88 shares during the last quarter. 60.47% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

A number of analysts have recently commented on ALAB shares. TD Cowen upped their price target on Astera Labs from $225.00 to $425.00 and gave the company a “hold” rating in a research note on Monday, July 13th. Weiss Ratings upgraded shares of Astera Labs from a “hold (c-)” rating to a “hold (c)” rating in a report on Thursday, May 21st. Barclays upped their target price on shares of Astera Labs from $200.00 to $325.00 and gave the company an “equal weight” rating in a research note on Monday, July 20th. UBS Group increased their target price on shares of Astera Labs from $205.00 to $400.00 and gave the stock a “neutral” rating in a report on Monday, June 29th. Finally, Evercore reissued an “outperform” rating and set a $297.00 price target on shares of Astera Labs in a research report on Tuesday, May 19th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the company. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus price target of $282.00.

Insider Activity

In other Astera Labs news, Director Jack R. Lazar sold 10,000 shares of the firm’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total transaction of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at approximately $26,882,106.96. This trade represents a 11.67% decrease in their position. The sale was disclosed in a filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Manuel Alba sold 8,491 shares of Astera Labs stock in a transaction that occurred on Wednesday, July 1st. The shares were sold at an average price of $458.38, for a total transaction of $3,892,104.58. Following the completion of the transaction, the director directly owned 286,863 shares in the company, valued at approximately $131,492,261.94. The trade was a 2.87% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders sold 1,676,845 shares of company stock worth $444,928,806. Corporate insiders own 10.40% of the company’s stock.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $282.52 on Tuesday. The company has a market capitalization of $48.43 billion, a P/E ratio of 190.89, a price-to-earnings-growth ratio of 3.38 and a beta of 3.66. The business has a 50-day moving average of $360.28 and a two-hundred day moving average of $226.92. Astera Labs, Inc. has a 1 year low of $97.89 and a 1 year high of $499.48.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 earnings per share for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The business had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same quarter in the previous year, the business posted $0.33 EPS. Astera Labs’s revenue for the quarter was up 93.5% on a year-over-year basis. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts anticipate that Astera Labs, Inc. will post 1.86 EPS for the current fiscal year.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.